Antibiotic stewardship: prescribing social norms
With a burgeoning world population, expansions in medical intervention, and intensifi ed agriculture, the need for antibiotic stewardship is increasingly clear.
1 Declining effi cacy of antimicrobial prophylaxis for surgery or chemotherapy, 2 and emergence of pan-resistant pathogens, 1 warn of a post-antibiotic era. In the evolutionary arms race of antimicrobial resistance, rejuvenating the neglected pipeline for new agents provides only a partial solution. 3 The key challenge worldwide is translating awareness of resistance into eff ective stewardship. 1 In the past decade, the UK has made notable progress. A high media profi le has provided political leverage to advance antimicrobial resistance up national health agendas, and surveillance systems for antibiotic consumption and resistance have been established. 4, 5 National targets to reduce broad-spectrum antibiotic use have been associated with declines in Clostridium diffi cile and meticillin-resistant Staphylococcus aureus. 5, 6 However, declining sensitivities to substitute antibiotics 4 suggest that without reducing total antibiotic consumption, we might be replacing rather than eliminating resistances. 7 Sustaining progress will require a major shift in prescribing and consumption norms.
A particular challenge in reducing antibiotic use is the disconnect between individual behaviour and populationlevel resistance. Avoiding overuse of a global common good requires making a diff use and unrecognised . 13 The UK is shown in red. *As defi ned in the WHO/ATX index (2012). DDDs=defi ned daily doses.
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C z e c h R e p u b li c I c e la n d P o r t u g a l U K S lo v a k i a B u lg a r i a S p a i n P o la n d I r e la n d L u x e m b o u r g I t a ly G r e e c e B e lg i u m F r a n c e N e t h e r la n d s E s t o n i a L a t v i a S w e d e n A u s t r i a S lo v e n i a G e r m a n y D e n m a r k N o r w a y L i t h u a n i a H u n g a r y social cost visible and felt. There is increasing interest in applying behavioural science, particularly in primary-care prescribing. In the UK, 80-90% of human antibiotic use occurs in the community, and large variation in prescribing rates are seen. 5 In a recent UK survey of over 1000 general practitioners (GPs), 28% reported prescribing antibiotics several times a week when uncertain of their necessity. 8 In The Lancet, Michael Hallsworth and colleagues 9 provide evidence that social norm feedback to prescribers can be an eff ective method to reduce total antibiotic consumption in ambulatory care. Their national pragmatic randomised controlled trial (RCT) assessed two interventions targeting 1581 GP practices in England with the highest antibiotic prescribing rates in their areas. In the fi rst intervention, GP practices in the intervention group received letters from England's Chief Medical Offi cer, which highlighted that their practice had prescribing rates higher than 80% of neighbouring practices, and resources for supporting self-care and delayed antibiotic prescriptions. In the second intervention, original control and intervention groups were re-randomised to a patient education campaign (posters and leafl ets sent to practice managers) or a control group. During the fi rst intervention, the rate of antibiotic items dispensed per 1000 weighted population-the primary outcome measure-was 126·98 (95% CI 125·68-128·27) in the intervention group and 131·25 (130·33-132·16) in the control group (incidence rate ratio [IRR] 0·967, 95% CI 0·957-0·977; p<0·0001). Over 6 months, this between group diff erence of 4·27 (3·3%) equated to 73 406 fewer antibiotic prescriptions. The patientoriented intervention did not yield a signifi cant additional benefi t (antibiotic items dispensed per 1000 population: 135·00 [95% CI 133·77-136·22] in the patient-focused intervention group vs 133·98 [133·06-134·90] in the control group; IRR 1·01, 95% CI 1·00 to 1·02; p=0·105).
Ethical and logistical considerations mean that most antibiotic stewardship interventions are assessed by observational or quasi-experimental studies. 10 The effi cient experimental design of this study strengthens confi dence in causality. Reassuringly, the eff ect size was congruent with previous investigations on antibiotic prescriber feedback, although contamination through changes in antibiotic prescribing in controls could have led to an underestimate. Controls for patient characteristics and historic antibiotic use minimised common sources of confounding in cluster RCTs.
The investigators did not assess the eff ects of the interventions on microbiological (resistance) outcomes, and did not record data for appropriateness of antibiotic use or harms from underuse. However, previous national and international studies have linked large variation in primary-care antibiotic use to resistance. 4, 5, 11 Furthermore, the largest eff ects of the feedback intervention were during winter, and in macrolide and penicillin use: Sweden's Strama programme showed that the restriction of common antimicrobial drugs for upper respiratory tract infections did not lead to an increase in complications. 12 A more important limitation of Hallsworth and colleagues' study is the short timescale of the intervention. It is not clear whether reiteration would be equally eff ective and whether, given time, it would shift, or merely narrow, the national antibiotic prescribing distribution.
The national scale, pragmatic trial design, and low cost of the intervention suggest that social norm feedback could be eff ective and cost-saving in other settings. However, we note strong caveats. First, in a universal health-care system, the transaction costs of obtaining, publicising, and comparing prescribing data are low. Surveillance systems in other countries are increasingly being established, but with multiple providers aligned to diff erent sociodemographic or clinical populations, meaningful comparisons are likely to be diffi cult. Second, eff ectiveness depends upon the salience of social norms to practitioner and patient behaviour. The public and practitioners in the UK are a "prepared fi eld" after two decades of battling health-care-associated infections and with high media interest in resistance. 4, 5 The absence of eff ect reported for the patient-oriented intervention could refl ect saturation in public awareness. The reputational cost of deviance from prescribing norms, and use of a high-profi le messenger (the Chief Medical Offi cer) might not provide as much leverage elsewhere. Third, social norms are only helpful where they converge with policy aims. A key message from behavioural sciences is that social factors aff ecting antibiotic prescribing and consumption norms are complex and context dependent.
1, 11 Where health insurance or out-ofpocket expenditures predominate, doctor reputation and income depend upon answering patients' expectations for antibiotics. 2 If patients can "shop" for antibiotics over the counter, a "race to the bottom" can occur. Although usually mosquito-borne, these Plasmodium parasite infections are also transmitted by blood transfusion in endemic countries. In highly endemic areas, transfusion-transmitted malaria can result in no symptoms or fairly mild symptoms if recipients have previous exposure and are semiimmune. However, for those with no immunity, a s is often the case for young children, transfusiontransmitted malaria poses a very serious risk. Furthermore, because malaria risk is regional in many parts of Africa, non-immune recipients in less risky areas can be infected by donors who have spent time in endemic areas. In non-endemic countries, a risk of transfusion-transmitted malaria exists when blood donors have travelled to endemic countries, but this low risk is addressed eff ectively by either testing the Transfusion-transmitted malaria: is hope around the corner? intervention could reduce primary-care prescribing in England by 0·85%, against a 5-year aim of reducing prescribing in primary care by 4%. 5 Between 2000 and 2014, UK primary-care antibiotic use expanded by 46%, from 14·3 to 20·9 defi ned daily doses per 1000 inhabitantdays. 13 During the same period, antibiotic use fell in several European countries, and UK consumption is now twice that of the Netherlands (fi gure). 13 Inpatient consumption also continues to increase. 4, 5 Minimising discordance between public or practitioner norms and policy could be expected to sharpen effi cacy and sustainability of stewardship. The feedback intervention was notably cheaper than NHS England's potentially divisive fi nancial incentives for areas that reduce total antibiotic use by 1%. 5 The ethical principle of least restrictive means suggests self-regulation is preferable to top-down mandates. However, where externalities are high and evidence compelling (eg, seat-belt legislation or smoking bans), government may need to act early to create new norms before they are widely accepted.
Hallsworth and colleagues make a clear case for integrating behavioural approaches into antibiotic stewardship, but interventions will need tailoring to regional contexts. The urgent, worldwide, and ecological nature of antibiotic resistance suggests that behavioural interventions should complement, rather than replace, top-down strategies.
